{
  "DOI": "10.1007/s12687-023-00677-5",
  "ISSN": [
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-023-00677-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eThis qualitative study explored the motivators and barriers for genetic testing for individuals with aniridia. Semi-structured interviews were conducted with 8 participants. The main findings highlighted the complex and interrelated factors involved in the decision-making process, including family planning, learning about the specific pathogenic variant of the disease and having access to genetic testing. Benefits and potential risks of genetic testing for aniridia were also discussed. For participants, gaining knowledge about their condition was perceived as a benefit, while administrative issues and concerns around privacy were identified as risks. Increased access to quality information about genetic testing and to the service and associated resources are needed to better support people living with aniridia.\u003c/jats:p\u003e",
  "alternative-id": [
    "677"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "21 September 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "3 October 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all individual participants included in the study. This study was approved by the University of British Columbia Children’s \u0026 Women’s Research Ethics Board (H19-02433)."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Tam",
      "given": "Mallorie T.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Daboub",
      "given": "Alonso",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lou",
      "given": "Hayami",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Robillard",
      "given": "Julie M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ],
    "date-time": "2023-10-03T04:01:21Z",
    "timestamp": 1696305681000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        9
      ]
    ],
    "date-time": "2024-02-09T06:33:37Z",
    "timestamp": 1707460417000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        10
      ]
    ],
    "date-time": "2024-02-10T00:09:26Z",
    "timestamp": 1707523766850
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2024,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            10,
            3
          ]
        ],
        "date-time": "2023-10-03T00:00:00Z",
        "timestamp": 1696291200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            10,
            3
          ]
        ],
        "date-time": "2023-10-03T00:00:00Z",
        "timestamp": 1696291200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-023-00677-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-023-00677-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-023-00677-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "97-101",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "677_CR1",
      "unstructured": "Aniridia: MedlinePlus Genetics (2009) https://medlineplus.gov/genetics/condition/aniridia/. Accessed 9 Feb 2023"
    },
    {
      "DOI": "10.1016/j.ajo.2015.05.026",
      "author": "S Benjaminy",
      "doi-asserted-by": "publisher",
      "first-page": "408",
      "journal-title": "Am J Ophthalmol",
      "key": "677_CR2",
      "unstructured": "Benjaminy S, Kowal SP, MacDonald IM, Bubela T (2015) Communicating the promise for ocular gene therapies: challenges and recommendations. Am J Ophthalmol 160:408–415. https://doi.org/10.1016/j.ajo.2015.05.026",
      "volume": "160",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.oftal.2012.07.006",
      "author": "F Blanco-Kelly",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "Arch Soc Esp Oftalmol",
      "key": "677_CR3",
      "unstructured": "Blanco-Kelly F, Villaverde-Montero C, Lorda-Sánchez I, Millán JM, Trujillo-Tiebas MJ, Ayuso C (2013) Guidelines for genetic study of Aniridia. Arch Soc Esp Oftalmol 88:145–152. https://doi.org/10.1016/j.oftal.2012.07.006",
      "volume": "88",
      "year": "2013"
    },
    {
      "DOI": "10.1586/14737159.2015.1081057",
      "author": "JPW Chiang",
      "doi-asserted-by": "publisher",
      "first-page": "1269",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "677_CR4",
      "unstructured": "Chiang JPW, Lamey T, McLaren T, Thompson JA, Montgomery H, De Roach J (2015) Progress and prospects of next-generation sequencing testing for inherited retinal dystrophy. Expert Rev Mol Diagn 15:1269–1275. https://doi.org/10.1586/14737159.2015.1081057",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.preteyeres.2022.101133",
      "author": "A Daruich",
      "doi-asserted-by": "publisher",
      "first-page": "101133",
      "journal-title": "Prog Retin Eye Res",
      "key": "677_CR5",
      "unstructured": "Daruich A, Duncan M, Robert MP, Lagali N, Semina EV, Aberdam D, Ferrari S et al (2023) Congenital aniridia beyond black eyes: from phenotype and novel genetic mechanisms to innovative therapeutic approaches. Prog Retin Eye Res 95:101133. https://doi.org/10.1016/j.preteyeres.2022.101133",
      "volume": "95",
      "year": "2023"
    },
    {
      "DOI": "10.3390/jpm12030477",
      "author": "AA Dwyer",
      "doi-asserted-by": "publisher",
      "first-page": "477",
      "journal-title": "J Pers Med",
      "key": "677_CR6",
      "unstructured": "Dwyer AA, Uveges MK, Dockray S, Smith N (2022) Exploring rare disease patient attitudes and beliefs regarding genetic testing: implications for person-centered care. J Pers Med 12:477. https://doi.org/10.3390/jpm12030477",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.1111/ceo.12159",
      "author": "RL Gillespie",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Clin Exp Ophthalmol",
      "key": "677_CR7",
      "unstructured": "Gillespie RL, Hall G, Black GC (2014) Genetic testing for inherited ocular disease: delivering on the promise at last? Clin Exp Ophthalmol 42:65–77. https://doi.org/10.1111/ceo.12159",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41436-020-0809-2",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "1311",
      "journal-title": "Genet Med",
      "key": "677_CR8",
      "unstructured": "Goranitis I, Best S, Christodoulou J, Stark Z, Boughtwood T (2020) The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments. Genet Med 22:1311–1319. https://doi.org/10.1038/s41436-020-0809-2",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1111/j.1755-3768.2008.01427.x",
      "author": "H Lee",
      "doi-asserted-by": "publisher",
      "first-page": "708",
      "journal-title": "Acta Ophthalmol",
      "key": "677_CR9",
      "unstructured": "Lee H, Khan R, O’Keefe M (2008) Aniridia: current pathology and management. Acta Ophthalmol 86:708–715. https://doi.org/10.1111/j.1755-3768.2008.01427.x",
      "volume": "86",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41434-022-00364-z",
      "author": "HG Mack",
      "doi-asserted-by": "publisher",
      "first-page": "336",
      "journal-title": "Gene Ther",
      "key": "677_CR10",
      "unstructured": "Mack HG, Britten-Jones AC, McGuinness MB, Chen FK, Grigg JR, Jamieson RV, Edwards TL et al (2023) Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia. Gene Ther 30:336–346. https://doi.org/10.1038/s41434-022-00364-z",
      "volume": "30",
      "year": "2023"
    },
    {
      "key": "677_CR11",
      "unstructured": "Moosajee M, Hingorani M, Moore AT (2018) PAX6-Related Aniridia. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, LJH B, Gripp KW, Amemiya A (eds) GeneReviews®. University of Washington, Seattle, Seattle (WA) http://www.ncbi.nlm.nih.gov/books/NBK1360/. Accessed 9 Feb 2023."
    },
    {
      "DOI": "10.1038/ejhg.2016.73",
      "doi-asserted-by": "publisher",
      "key": "677_CR12",
      "unstructured": "Richardson R, Hingorani M, Van Heyningen V, Gregory-Evans C, Moosajee M (2016) Clinical utility gene card for: Aniridia. Eur J Hum Genet 24. https://doi.org/10.1038/ejhg.2016.73"
    },
    {
      "DOI": "10.1002/wmh3.469",
      "author": "JM Robillard",
      "doi-asserted-by": "publisher",
      "first-page": "518",
      "journal-title": "World Med Health Policy",
      "key": "677_CR13",
      "unstructured": "Robillard JM, Feng TL, Kabacińska K (2021) Access to genetic testing for rare diseases: existing gaps in public-facing information. World Med Health Policy 13:518–525. https://doi.org/10.1002/wmh3.469",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41431-023-01282-3",
      "author": "I Strnadová",
      "doi-asserted-by": "publisher",
      "first-page": "1057",
      "journal-title": "Eur J Hum Genet",
      "key": "677_CR14",
      "unstructured": "Strnadová I, Loblinzk J, Scully JL, Danker J, Tso M, Jackaman KM, Dunn M et al (2023) “I Am Not a Number!” Opinions and preferences of people with intellectual disability about genetic healthcare. Eur J Hum Genet 31:1057–1065. https://doi.org/10.1038/s41431-023-01282-3",
      "volume": "31",
      "year": "2023"
    },
    {
      "DOI": "10.1001/jamaophthalmol.2013.4509",
      "author": "JL Wiggs",
      "doi-asserted-by": "publisher",
      "first-page": "1265",
      "journal-title": "JAMA Ophthalmol",
      "key": "677_CR15",
      "unstructured": "Wiggs JL, Pierce EA (2013) Genetic testing for inherited eye disease: who benefits? JAMA Ophthalmol 131:1265–1266. https://doi.org/10.1001/jamaophthalmol.2013.4509",
      "volume": "131",
      "year": "2013"
    }
  ],
  "reference-count": 15,
  "references-count": 15,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-023-00677-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Short Communication: Lived experience perspectives on genetic testing for a rare eye disease"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}